| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| F809591 | MACKLIN | 亚叶酸钙,水合物 | 98% | 193元/1g; 599元/5g; 2473元/25g; 7422元/100g; | 展开 |
|
| F792783 | MACKLIN | 亚叶酸钙, 水合物 | 10mM in Water | 198元/1ml; | 展开 |
|
| C2235 | TCI | Calcium Folinate | >98.0%(T)(HPLC) | 220元/1G; 730元/5G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C20H21CaN7O7 = 511.51 | | 外观与形状(20℃) | 固体 | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 光,湿气 (吸湿) | | 包装和容器 | 1G-带有塑料内管的玻璃瓶 (查看图片) | | 相关CAS RN | 58-05-9&6035-45-6&2060570-47-8 | | Reaxys-RN | 5723924 | | PubChem物质ID | 87560126 | | MDL编号 | MFCD00006704 |
技术规格 | Appearance | Light orange to Yellow to Green powder to crystaline | | Purity(HPLC) | min. 98.0 area% | | Purity(Chelometric Titration) | min. 98.0 %(calcd.on anh.substance) | | Water | max. 17.0 % |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H315 : 造成皮肤刺激。
H319 : 造成严重眼刺激。
| | 防范说明 | P264 : 作业后彻底清洗皮肤。
P280 : 戴防护手套/戴防护眼罩/戴防护面具。
P302 + P352 : 如皮肤沾染：用水充分清洗。
P337 + P313 : 如仍觉眼刺激：求医/就诊。
P305 + P351 + P338 : 如进入眼睛：用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出，取出隐形眼镜。继续冲洗。
P362+P364 : 脱掉沾污的衣服，清洗后方可重新使用。
P332 + P313 : 如发生皮肤刺激：求医/就诊。
|
相关法规 |
| 332047 | J&K | Folinic acid calcium salt hydrate | 98% | 494元/1G; 1568元/5G; | 展开 |
基本信息 | 分子式 | C20H21CaN7O7·xH2O | | 分子量 | 511.51(anhydrous) | | 熔点 | 240-250 | | MDL编码 | MFCD00006704 | | Beilstein | 5723924 |
一般描述 亚叶酸，也称亚叶酸钙，通常以无定形粉末形式存在并且没有气味。这种维生素B9的活化形式为灰白色至浅米色。叶酸（FA）是水溶性维生素。亚叶酸是四氢叶酸的5-甲酰基衍生物，是叶酸的还原形式。5-甲酰基-5,6,7,8-四氢叶酸的非对映异构体的（6R，S）-混合物钙盐。 应用 亚叶酸钙盐水合物已被用于制备外用的1％和2.5％亚叶酸乳膏，可用于伤口愈合研究。它还被用作化学成分明确的中国仓鼠卵巢培养基（CD-CHO）的成分，用于培养CHO DUKX B11。叶酸拮抗剂通过结合二氢叶酸还原酶并阻滞叶酸转化为四氢叶酸盐发挥作用，而亚叶酸钙则可抵消叶酸拮抗剂的作用。在医学上，亚叶酸钙在甲氨蝶呤治疗后用于降低甲氨蝶呤的毒性。亚叶酸钙还可用于增强癌症治疗中 5-氟尿嘧啶的细胞毒性效应。 生化/生理作用 亚叶酸可作为辅因子并参与一碳转移反应（one-carbon-transfer reaction）。它有助于改善大鼠的伤口愈合。亚叶酸在自闭症儿童中起重要作用，可增强其言语交流。 安全信息 | 图形或危害标志 |  | | 提示语 | Danger | | 危险说明 | H315
H317
H319
H334
H335 | | 防范说明 | P261
P280
P305+P351+P338
P342+P311 | | WGK | 3 | | RTECS | MA0600500 |
|
| H60181 | Alfa Aesar | Folinic acid calcium salt hydrate | 98% | 2369元/250mg; 6697元/1g; | 展开 |
基本信息 MDL
MFCD00149463 EINECS
216-082-8 分子式
C20H21CaN7O7?xH2O 分子量
511.51 (anhy) 形态
Solid Beilstein
5723924 GHS危害和防范说明 GHS符号
Hazard Statements
H315-H319-H334-H317-H335
Causes skin irritation.Causes serious eye irritation.May cause allergy or asthma symptoms or breathing difficulties if inhaled.May cause an allergic skin reaction.May cause respiratory irritation. Precautionary Statements
P284-P261-P280a-P305+P351+P338-P405-P501a
Wear respiratory protection.Avoid breathing dust/fume/gas/mist/vapours/spray.Wear protective gloves and eye/face protection.IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.Store locked up.Dispose of contents/container in accordance with local/regional/national/international regulations. 安全信息 危险类别
36/37/38-42/43
Irritating to eyes, respiratory system and skin.May cause sensitization by inhalation and skin contact. 安全等级
22-24-26-37-45-60
Do not breathe dust.Avoid contact with skin.In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).This material and its container must be disposed of as hazardous waste 欧盟危险品标志
 TSCA
否 |
| PHR1541 | Supelco | Leucovorin Calcium | Pharmaceutical Secondary Standard; Certified Reference Material | 1596.92元/1 G; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. 应用 Leucovorin Calcium may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by high performance liquid chromatography (HPLC).
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC1687 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C20H21CaN7O7 | | 分子量 | 511.50 | | EC 号 | 216-082-8 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material
pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | ampule of 1 g | | technique(s) | HPLC: suitable
gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 923
traceable to PhEur C0250000
traceable to USP 1358004 | | 储存温度 | 2-8℃ | | InChI | 1S/C20H23N7O7.Ca/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);/q;+2/p-2/t12?,13-;/m0./s1 | | InChI key | KVUAALJSMIVURS-ZEDZUCNESA-L |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H315 - H317 - H319 - H334 - H335 | | 预防措施声明 | P280 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| F7878 | Supelco | Folinic acid calcium salt hydrate | analytical standard | 1527.58元/100 MG; 4917.17元/500 MG; 9364.3元/1 G; | 展开 |
产品说明 一般描述 亚叶酸钙盐水合物是一种广泛使用的癌症治疗药物，因为它可以减少毒副作用，并有助于改善药物在肿瘤组织中的蓄积。 应用 有关合适仪器技术的更多信息，请参考产品′s分析证书。如需进一步支持，请联系技术服务。
亚叶酸钙盐水合物已被用作一种测试化合物，以使用酶联免疫吸附测定(ELISA)技术研究其对参与神经炎症的小胶质细胞的影响。
亚叶酸钙盐水合物已被用作一种测试化合物，用于通过酶联免疫吸附测定(ELISA)技术研究其对参与神经炎症的小胶质细胞的影响。亚叶酸钙盐水合物已被用作一种分析试剂，用于通过湍流色谱-串联质谱联用法定量测定生物样品中的甲氨蝶呤及其代谢物。
叶酸拮抗剂通过结合二氢叶酸还原酶并阻滞叶酸转化为四氢叶酸盐发挥作用，而亚叶酸钙则可抵消叶酸拮抗剂的作用。在医学上，亚叶酸钙在甲氨蝶呤治疗后用于降低甲氨蝶呤的毒性。亚叶酸钙还可用于增强癌症治疗中 5-氟尿嘧啶的细胞毒性效应。 包装 1 g in glass bottle
100, 500 mg in glass bottle 基本信息 | 经验(实验)分子式 | C20H21CaN7O7 · xH2O | | 分子量 | 511.50 (anhydrous basis) | | Beilstein | 5723924 | | PubChem化学物质编号 | 24894951 | | NACRES | NA.24 |
产品性质 | 生物来源 | synthetic (organic) | | 质量水平 | 100 | | 等级 | analytical standard | | 测定 | ≥90.0% | | technique(s) | HPLC: suitable
gas chromatography (GC): suitable | | 颜色 | yellow to orange | | mp | 240-250 ℃ | | application(s) | forensics and toxicology
pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | [Ca++].[H]O[H].[H]C(=O)N1C(CNc2ccc(cc2)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)CNc3nc(N)nc(O)c13 |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H315 - H317 - H319 - H334 - H335 | | 预防措施声明 | P261 - P264 - P280 - P302 + P352 - P304 + P340 + P312 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 47612 | Sigma-Aldrich | Folinic acid calcium salt hydrate | BioXtra, ≥99.0% (HPLC) | 3118.83元/250 MG; 9867.42元/1 G; | 展开 |
产品说明 一般描述 亚叶酸，也称亚叶酸钙，通常以无定形粉末形式存在并且没有气味。这种维生素B9的活化形式为灰白色至浅米色。叶酸(FA)是水溶性维生素。亚叶酸是四氢叶酸的5-甲酰基衍生物，是叶酸的还原形式。
5-甲酰基-5,6,7,8-四氢叶酸的非对映异构体的(6R，S)-混合物钙盐。 应用 亚叶酸钙盐水合物已被用于制备外用的1％和2.5％亚叶酸乳膏，可用于伤口愈合研究。它还被用作化学成分明确的中国仓鼠卵巢培养基(CD-CHO)的成分，用于培养CHO DUKX B11。
叶酸拮抗剂通过结合二氢叶酸还原酶并阻滞叶酸转化为四氢叶酸盐发挥作用，而亚叶酸钙则可抵消叶酸拮抗剂的作用。在医学上，亚叶酸钙在甲氨蝶呤治疗后用于降低甲氨蝶呤的毒性。亚叶酸钙还可用于增强癌症治疗中 5-氟尿嘧啶的细胞毒性效应。 生化/生理作用 亚叶酸可作为辅因子并参与一碳转移反应(one-carbon-transfer reaction)。它有助于改善大鼠的伤口愈合。亚叶酸在自闭症儿童中起重要作用，可增强其言语交流。 其他说明 综述 基本信息 | 经验(实验)分子式 | C20H21CaN7O7 · xH2O | | 分子量 | 511.50 (anhydrous basis) | | Beilstein | 5723924 | | PubChem化学物质编号 | 24871209 |
产品性质 | 质量水平 | 200 | | 生物来源 | synthetic | | 产品线 | BioXtra | | 测定 | ≥99.0% (HPLC) | | 形式 | powder or crystals | | technique(s) | cell culture | mammalian: suitable | | 颜色 | white to faint yellow | | mp | 240-250 ℃ | | application(s) | cell analysis | | SMILES string | [Ca++].[H]O[H].[H]C(=O)N1C(CNc2ccc(cc2)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)CNc3nc(N)nc(O)c13 |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H315 - H317 - H319 - H334 - H335 | | 预防措施声明 | P280 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
|
| C0250000 | | Calcium Folinate | European Pharmacopoeia (EP) Reference Standard | 1573.02元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. Calcium folinate (CF) is a folic acid derivative. It is a naturally occurring compound that has a vital role in various metabolic pathways. Calcium folinate (CF) drug is also used in the treatment of anemia, during pregnancy. 应用 叶酸拮抗剂通过结合二氢叶酸还原酶并阻滞叶酸转化为四氢叶酸盐发挥作用，而亚叶酸钙则可抵消叶酸拮抗剂的作用。在医学上，亚叶酸钙在甲氨蝶呤治疗后用于降低甲氨蝶呤的毒性。亚叶酸钙还可用于增强癌症治疗中 5-氟尿嘧啶的细胞毒性效应。 包装 Unit quantity: 110 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H21CaN7O7 · xH2O | | 分子量 | 511.50 (anhydrous basis) | | Beilstein | 5723924 | | NACRES | NA.24 |
产品性质 | 生物来源 | synthetic | | 等级 | pharmaceutical primary standard | | agency | EP | | 形式 | solid | | manufacturer/tradename | EDQM | | technique(s) | gas chromatography (GC): suitable
liquid chromatography (LC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | [Ca++].[H]O[H].[H]C(=O)N1C(CNc2ccc(cc2)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)CNc3nc(N)nc(O)c13 |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H315 - H317 - H319 - H334 - H335 | | 预防措施声明 | P261 - P264 - P280 - P302 + P352 - P304 + P340 + P312 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0002071 | | Calcium folinate for system suitability | European Pharmacopoeia (EP) Reference Standard | 1313.88元/ ; | 展开 |
产品说明 一般描述 Calcium folinate, the reduced form of folic acid, finds application in the treatment of methotrexate overdose and in high-dose methotrexate chemotherapy as a chemotherapy protective drug to bring down the latter′s toxicity. When combined with fluorouracil, it is reported to be effective in the management of bowel cancer wherein it acts by inhibiting thymidylate synthase and augmenting the effect of fluorouracil.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 应用 Calcium folinate for system suitability may be used as an analytical reference standard for the determination of the analyte in pharmaceutical formulations by liquid chromatography.
叶酸拮抗剂通过结合二氢叶酸还原酶并阻滞叶酸转化为四氢叶酸盐发挥作用，而亚叶酸钙则可抵消叶酸拮抗剂的作用。在医学上，亚叶酸钙在甲氨蝶呤治疗后用于降低甲氨蝶呤的毒性。亚叶酸钙还可用于增强癌症治疗中 5-氟尿嘧啶的细胞毒性效应。 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H21CaN7O7 · xH2O | | 分子量 | 511.50 (anhydrous basis) | | Beilstein | 5723924 |
产品性质 | 生物来源 | synthetic | | 等级 | pharmaceutical primary standard | | agency | EP | | 形式 | solid | | manufacturer/tradename | EDQM | | technique(s) | gas chromatography (GC): suitable
liquid chromatography (LC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | −20℃ | | SMILES string | [Ca++].[H]O[H].[H]C(=O)N1C(CNc2ccc(cc2)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)CNc3nc(N)nc(O)c13 |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H315 - H317 - H319 - H334 - H335 | | 预防措施声明 | P261 - P264 - P280 - P280 - P304 + P340 + P312 - P342 + P311 | | 危险分类 | Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1358004 | USP | Leucovorin Calcium | United States Pharmacopeia (USP) Reference Standard | 3365.61元/500 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H21CaN7O7 | | 分子量 | 511.50 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | InChI | 1S/C20H23N7O7.Ca/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);/q;+2/p-2/t12?,13-;/m0./s1 | | InChI key | KVUAALJSMIVURS-ZEDZUCNESA-L |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H315 - H317 - H319 - H334 - H335 | | 预防措施声明 | P261 - P280 - P284 - P304 + P340 - P305 + P351 + P338 - P342 + P311 | | 危险分类 | Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1286027 | USP | Folic Acid Related Compound A | United States Pharmacopeia (USP) Reference Standard | 3304.65元/50 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H21CaN7O7 | | 分子量 | 511.50 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | InChI | 1S/C20H23N7O7.Ca/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);/q;+2/p-2/t12?,13-;/m0./s1 | | InChI key | KVUAALJSMIVURS-ZEDZUCNESA-L |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H315 - H317 - H319 - H334 - H335 | | 预防措施声明 | P261 - P280 - P284 - P304 + P340 - P305 + P351 + P338 - P342 + P311 | | 危险分类 | Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 036567 | Fluorochem | 5-Formyl-5,6,7,8-tetrahydrofolic acid calcium salt | 97% | 374元/250mg; 836元/1g; 2706元/5g; 13200元/25g; | 展开 |
基本信息 | CAS Number | 1492-18-8 | | MDL Number | MFCD00006704 |
安全信息 | 图形或危害标志 | | | 危险性说明 | H315: Causes skin irritation.
H319: Causes serious eye irritation.
H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed.
P260: Do not breathe .
P261: Avoid breathing .
P264: Wash hands thoroughly after handling.
P271: Use only outdoors or in a well-ventilated area.
P280: Wear .
P302 + P352: IF ON SKIN: Wash with plenty of soap and water.
P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing..
P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P312: Call a POISON CENTER or doctor/physician if you feel unwell.
P321: Specific treatment (see relevant procedures. on this label).
P332 + P313: If skin irritation occurs: Get medical advice/ attention.
P337 + P313: If eye irritation persists: Get medical advice/attention.
P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P362: Take off contaminated clothing and wash before reuse.
P403: Store in a well-ventilated place.
P403 + P233: Store in a well-ventilated place. Keep container tightly closed.
P405: Store locked up.
P501: Dispose of contents/container to in accordance with local regulation .
|
|
m.cnreagent.com